0000899243-22-039506.txt : 20221229 0000899243-22-039506.hdr.sgml : 20221229 20221229143448 ACCESSION NUMBER: 0000899243-22-039506 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221227 FILED AS OF DATE: 20221229 DATE AS OF CHANGE: 20221229 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Silver Brian M. CENTRAL INDEX KEY: 0001860597 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40603 FILM NUMBER: 221498400 MAIL ADDRESS: STREET 1: C/O TSCAN THERAPEUTICS, INC. STREET 2: 830 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TScan Therapeutics, Inc. CENTRAL INDEX KEY: 0001783328 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 825282075 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 880 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 857-399-9500 MAIL ADDRESS: STREET 1: 880 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-12-27 0 0001783328 TScan Therapeutics, Inc. TCRX 0001860597 Silver Brian M. C/O TSCAN THERAPEUTICS, INC. 830 WINTER STREET WALTHAM MA 02451 0 1 0 0 Chief Financial Officer Voting Common Stock 2022-12-27 4 P 0 2842 1.5047 A 29727 D Voting Common Stock 2022-12-28 4 P 0 3158 1.5646 A 32885 D The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $1.46 to $1.55, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $1.55 to $1.57, inclusive. /s/ Brian M. Silver 2022-12-29